Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Tim O'Brien, Keith Warner, Michael Henighan


DNAnexus has appointed Tim O'Brien as vice president of sales. He joins the company from Oracle's Health Sciences Global Business Unit, where he led the America's healthcare sales team. Previously, he held sales and sales management positions at IDBS, Infotrieve, and Life Technologies.

WaferGen has appointed Keith Warner as chief operating officer and Michael Henighan as chief financial officer.

Warner has served as a consultant to several life science investment firms since 2009 and was also previously vice president of worldwide marketing at Novartis/Chiron and CEO of Biodesix.

Henighan was a founder and CFO of Aplegen prior to joining WaferGen. Before that, he served as CFO or corporate controller at Alpha Innotech, HemoSense, and Cholestech.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.